Clinical Trials List
2025-08-01 - 2027-11-08
Phase I
Recruiting3
ICD-10C69.40
Malignant neoplasm of unspecified ciliary body
ICD-10C69.41
Malignant neoplasm of right ciliary body
ICD-10C69.42
Malignant neoplasm of left ciliary body
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9190.0
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 蔡承志 無
- TSU-YI CHAO 無
- 莊博雅 無
- Yao-Yu Hsieh 無
- HUI-WEN LIU 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mu-Hsin Chang 無
- Chien-An Liu 無
- Tien-Hua Chen 無
- 姜乃榕 無
- Ming-Huang Chen 無
- Yi-Ping Hung 無
- Muh-Hwa Yang 無
- San-Chi Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳尚俊 無
- Chih-Hung Hsu 無
- 陳國興 無
- TSUNG-HAO LIU 無
- 吳宗哲 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- 廖斌志 無
- Jih-Hsiang Lee 無
- 徐偉勛 無
- 楊景堯 無
- 蔡子修 無
- CHAO-CHI HO CHAO-CHI HO 無
- YEN-TING LIN 無
- 莊建淮 無
- 廖唯昱 無
- Yu-Chieh Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
60 participants
